nandrolone has been researched along with Muscular Dystrophy in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (91.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afzal, E; Afzal, S; Ardestani, MS; Asadian, M; Bagheri, M; Cohan, RA; Darvishmohammadi, T; Dehqanian, M; Farjadian, F; Ghaffari, M; Ghalandarlaki, N; Golvajoee, MS; Gravand, A; Keyhanvar, P; Mahjoubi, P; Omoomi, N; Zakeri, S | 1 |
| BEKENY, G; KRAFT, F; LANG, S | 2 |
| DOWBEN, RM | 1 |
| BROWN, IA; JAMES, EM | 1 |
| HANTSCHMANN, N; MATZELT, D; MERTENS, HG; NOWAKOWSKI, H | 1 |
| BARWICK, DD; NEWELL, DJ; WALTON, JN | 1 |
| WORM, J | 1 |
| WALTON, JN | 1 |
| HEYCK, H; LAUDAHN, G; LUEDERS, CJ; MUELLER-STEPHANN, H; SCHMIDT-PETER, P | 1 |
| Amanova, ZN; Avakian, GN; Badalian, LO; Temin, PA | 1 |
| Kavtaradze, NP; Mindadze, BA; Natriashvili, GD | 1 |
12 other study(ies) available for nandrolone and Muscular Dystrophy
| Article | Year |
|---|---|
Nanolipodendrosome-loaded glatiramer acetate and myogenic differentiation 1 as augmentation therapeutic strategy approaches in muscular dystrophy.
Topics: Animals; Body Weight; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Glatiramer Acetate; Liposomes; Male; Mice; Microscopy, Electron, Transmission; Muscle, Skeletal; Muscular Dystrophies; MyoD Protein; Nandrolone; Nanoparticles; Particle Size; Peptides | 2013 |
[The use of durabolin (19-nor-androstenolone phenylpropionate) in the therapy of progressive muscular dystrophy].
Topics: Dehydroepiandrosterone; Muscular Dystrophies; Nandrolone; Phenylpropionates; Testosterone | 1960 |
[Use of durabolin (19-nor-androstenolone phenylpropionate) in the therapy of progressive muscular dystrophy].
Topics: Dehydroepiandrosterone; Muscular Dystrophies; Nandrolone; Phenylpropionates; Testosterone | 1960 |
Prolonged survival of dystrophic mice treated with 17 alpha-ethyl-19-nortestosterone.
Topics: Animals; Mice; Muscular Dystrophies; Nandrolone; Testosterone | 1959 |
Nandrolone-phenpropionate in progressive muscular dystrophy.
Topics: Muscular Dystrophies; Nandrolone; Testosterone | 1961 |
[On the treatment of muscular diseases by anabolic steroids. II. Clinical experiences].
Topics: Humans; Methyltestosterone; Muscular Diseases; Muscular Dystrophies; Nandrolone | 1962 |
Methandrostenolone and nandrolone decanoate in muscular dystrophy; a controlled trial.
Topics: Anatomy; Humans; Methandrostenolone; Muscular Dystrophies; Nandrolone; Nandrolone Decanoate; Steroids | 1963 |
[Progressive muscular dystrophy treated with Durabolin].
Topics: Humans; Muscular Dystrophies; Nandrolone | 1962 |
TREATMENT OF MUSCULAR DYSTROPHY.
Topics: Anabolic Agents; Biomedical Research; Humans; Methandrostenolone; Muscular Dystrophies; Nandrolone; Norethandrolone; Nucleosides; Nucleotides; Pharmacology; Steroids; Toxicology | 1964 |
ANABOLIC STEROIDS AND DIGITOXIN IN THE TREATMENT OF PROGRESSIVE MUSCULAR DYSTROPHY.
Topics: Adolescent; Child; Clinical Enzyme Tests; Digitoxin; Drug Therapy; Enzymes; Humans; Infant; Muscle Proteins; Muscles; Muscular Dystrophies; Nandrolone; Pathology; Testosterone Congeners; Toxicology | 1965 |
[Effect of retabolyl on the dynamics of urinary catecholamine and DOPA excretion and electroneuromyographic indices in patients with Duchenne's myodystrophy].
Topics: Catecholamines; Child; Dihydroxyphenylalanine; Electrodiagnosis; Electromyography; Humans; Muscular Dystrophies; Nandrolone; Nandrolone Decanoate; Neural Conduction | 1984 |
[Course of Duchenne muscular dystrophy and its treatment].
Topics: Allopurinol; Child; Combined Modality Therapy; Follow-Up Studies; Humans; Male; Methandrostenolone; Muscular Dystrophies; Nandrolone; Nandrolone Decanoate; Neostigmine; Syndrome; Vitamins | 1986 |